Health
Fortune or foresight? AstraZeneca and Oxford’s stories clash on COVID-19 vaccine – The Japan Times
The two partners have given conflicting accounts of how they came upon the most effective dosing pattern for their COVID-19 vaccine.
LONDON – AstraZeneca and Oxford University have given conflicting accounts of how they came upon the most effective dosing pattern for their COVID-19 vaccine, a rare instance of public dissension between major institutions collaborating on a pivotal project.
The discrepancy centers on the regimen administered to a smaller group of volunteers in the late-stage trials, of half a dose followed by a full dose. This diverged from the original plan of two full doses, given to the majority of participants.
…
-
Business23 hours agoForget CBA and buy these high-yield ASX dividend shares
-
Noosa News23 hours agoThe Almond Ashes sees Australia and India mix business and cricket
-
General23 hours agoUK PM ready to ‘shelter’ businesses from tariff storm
-
General23 hours agoWhy do states and territories have different school holidays?